Sanofi Sponsored ADR is a company in the U.S. stock market and it is a holding in 11 U.S.-traded ETFs. SNY has around 1.6M shares in the U.S. ETF market. The largest ETF holder of SNY is the First Trust Value Line Dividend Index Fund (FVD), with approximately 896.93K shares. Investors may also find of interest that the ETF with the largest allocation to SNY stock is VanEck Vectors Pharmaceutical ETF (PPH), with a portfolio weight of 5.14%. On average, U.S. ETFs allocate 1.83% of SNY to their portfolios.

Additionally, SNY is a favorite stock for Depositary Receipts and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with SNY as a holding is the First Trust Value Line Dividend Index Fund (FVD), with a return of 11.28%.